BAY 11-7082 is a broad-spectrum inhibitor with anti-inflammatory activity against multiple targets.

BAY 11-7082 is a broad-spectrum inhibitor with anti-inflammatory activity against multiple targets.
复制标题

DOI:
10.1155/2012/416036
复制
发表时间:
2012
影响因子:
4.6
通讯作者:
Cho JY
Cho JY
中科院分区:
医学3区
文献类型:
--
作者:
Lee J;Rhee MH;Kim E;Cho JY

文献摘要

参考文献

被引文献

相似文献

BAY 11-7082 (BAY) 是一种 κB 激酶 (IKK) 抑制剂,具有抗癌、神经保护和抗炎作用等药理活性。在这项研究中,进一步表征了 BAY 药理学目标途径,以确定该化合物如何同时抑制各种反应。原代和癌性(RAW264.7细胞)巨噬细胞被脂多糖(Toll样受体4的配体)激活。正如之前报道的,BAY强烈抑制一氧化氮、前列腺素E2和肿瘤坏死因子-α的产生,并减少核因子-κB主要亚基p65的易位及其上游信号转导事件,例如IκBα、IKK和Akt的磷酸化。此外,BAY还通过抑制细胞外信号相关激酶、p38、TANK结合蛋白和Janus激酶-2的磷酸化或激活,抑制激活蛋白-1、干扰素调节因子-3、信号转导子和转录激活子-1的易位和激活。这些数据强烈表明,BAY 是一种具有多个靶点的抑制剂,可以作为开发具有多个炎症反应靶点的强效抗炎药物的先导化合物。
BAY 11-7082 (BAY) is an inhibitor of κB kinase (IKK) that has pharmacological activities that include anticancer, neuroprotective, and anti-inflammatory effects. In this study, BAY-pharmacological target pathways were further characterized to determine how this compound simultaneously suppresses various responses. Primary and cancerous (RAW264.7 cells) macrophages were activated by lipopolysaccharide, a ligand of toll-like receptor 4. As reported previously, BAY strongly suppressed the production of nitric oxide, prostaglandin E2, and tumor necrosis factor-α and reduced the translocation of p65, major subunit of nuclear factor-κB, and its upstream signaling events such as phosphorylation of IκBα, IKK, and Akt. In addition, BAY also suppressed the translocation and activation of activator protein-1, interferon regulatory factor-3, and signal transducer and activator of transcription-1 by inhibiting the phosphorylation or activation of extracellular signal-related kinase, p38, TANK-binding protein, and Janus kinase-2. These data strongly suggest that BAY is an inhibitor with multiple targets and could serve as a lead compound in developing strong anti-inflammatory drugs with multiple targets in inflammatory responses.
DOI: 10.1196/annals.1397.071
发表时间: 2007-01-01
期刊: SIGNAL TRANSDUCTION PATHWAYS, PT D
影响因子: --
作者:
Dos Santos, S.;Delattre, A.-I.;Raes, M.
通讯作者: Raes, M.
DOI: 10.1016/j.leukres.2005.05.004
发表时间: 2005-12-01
期刊: LEUKEMIA RESEARCH
影响因子: 2.7
作者:
García, MG;Alaniz, L;Alvarez, E
通讯作者: Alvarez, E
DOI: 10.1016/j.lfs.2006.06.048
发表时间: 2006-10-19
期刊: LIFE SCIENCES
影响因子: 6.1
作者:
Jung, Ki Kyung;Lee, Hae Sung;Kang, Seog Youn
通讯作者: Kang, Seog Youn
DOI: 10.1691/ph.2011.0798
发表时间: 2011-04-01
期刊: PHARMAZIE
影响因子: 1.6
作者:
Kim, Min Ho;Yoo, Dae Sung;Cho, Jae Youl
通讯作者: Cho, Jae Youl
DOI: 10.1074/jbc.m109.000414
发表时间: 2009-05-22
影响因子: 4.8
作者:
Clark, Kristopher;Plater, Lorna;Cohen, Philip
通讯作者: Cohen, Philip